메뉴 건너뛰기




Volumn 10, Issue 4, 1999, Pages 377-384

The third-generation non-steroidal aromatase inhibitors: A review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer

Author keywords

Anastrozole; Aromatase inhibitors; Breast cancer; Hormonal therapy; Letrozole; Review; Vorozole

Indexed keywords

AMINOGLUTETHIMIDE; ANASTROZOLE; AROMATASE INHIBITOR; LETROZOLE; MEGESTROL ACETATE; VOROZOLE;

EID: 0032907539     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008368300827     Document Type: Review
Times cited : (121)

References (1)
  • 1
    • 0029804714 scopus 로고    scopus 로고
    • Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer
    • Geisler J, King N, Dowsett M et al. Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer. Br J Cancer 1996; 74: 1286-91.
    • (1996) Br J Cancer , vol.74 , pp. 1286-1291
    • Geisler, J.1    King, N.2    Dowsett, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.